TCL Archive FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC. March 30, 2001
TCL Archive Going private may allow US Oncology to restructure, respond to Medicare cuts; equity investment firm offers to purchase shares. April 23, 2004